Pennsylvania Superior Court Affirms $3M Topamax Birth Defect Verdict
PHILADELPHIA — A Pennsylvania Superior Court appeals panel on May 11 denied Janssen Pharmaceuticals Inc.’s appeal of a $3 million Topamax birth defect verdict, agreeing with the trial court that the...To view the full article, register now.
Already a subscriber? Click here to view full article